The epidemiology of diseases associated with HTLV-I and HTLV-II. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The epidemiology of diseases associated with HTLV-I and HTLV-II.

Infect Dis Clin North Am. 1987 Sep;1(3):501-10. Unique Identifier : AIDSLINE MED/89067401
Levine PH; Blattner WA; Division of Cancer Etiology, National Cancer Institute, Bethesda,; Maryland.

Abstract: Considerable progress is being made in the understanding of at least two diseases associated with HTLV-I, ATLL and TSP. While laboratory methodology has not yet permitted comparable advances in identifying diseases associated with HTLV-II, if any, it is likely that a greater understanding of this and other retroviruses will result from the increasing focus of attention in this area. As illustrated by a recent meeting on retroviruses in the nervous system, which included discussions on polymyositis and multiple sclerosis as well as TSP, ATLL, and AIDS, the number of diseases associated with retroviruses is likely to increase and, if the applications of research data to the control of malignancies associated with hepatitis B virus and Epstein-Barr virus are applicable, the future for improving control of HTLV-I-associated disease should be quite promising.
Keywords: Human HTLV-I Infections/*EPIDEMIOLOGY HTLV-II Infections/*EPIDEMIOLOGY Japan Leukemia, T-Cell/*EPIDEMIOLOGY/ETIOLOGY Lymphoma/EPIDEMIOLOGY Paraparesis, Tropical Spastic/*ETIOLOGY T-Lymphocytes West Indies JOURNAL ARTICLE REVIEW REVIEW, ACADEMIC

KWDhumanhtlv-iinfections/KWDepidemiologyhtlv-iiinfections/KWDepidemiologyjapanleukemia,t-cell/KWDepidemiology/etiologylymphoma/epidemiologyparaparesis,tropicalspastic/KWDetiologyt-lymphocyteswestindiesjournalarticlereviewreview,academic
890330
M8930509

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .